⚠ PREVIEW — highlighted items are placeholders awaiting your confirmation or real photos. Add ?live to the URL to preview the clean version.

3H Clinical Research Corporation

Advancing Urology Through Clinical Research

Dr. Lief and his team have helped define the bar for urologic research — giving patients access to tomorrow's treatments today.

Quick answer

Through 3H Clinical Research Corporation, Dr. Matthew Lief serves as Principal Investigator on phase 2 and phase 3 urologic clinical trials, currently focused on low testosterone, enlarged prostate (BPH), and urinary leakage. Participating patients may gain early access to emerging treatments while contributing to the advancement of urologic care.

Organization3H Clinical Research Corporation
Principal InvestigatorDr. Matthew S. Lief, MD, FACS
Trial phasesPhase 2 & phase 3
Focus areasLow testosterone · enlarged prostate (BPH) · urinary leakage
Cost to qualifying participantsTypically none (confirm per study)

Why research matters for patients

Clinical research is how new treatments are proven safe and effective before they reach the wider public. Because Dr. Lief is an active investigator, his patients can sometimes access promising therapies years before they're widely available — all under careful medical supervision.

Current research areas

  • Low testosterone treatment optimization
  • Enlarged prostate (BPH) innovative therapies
  • Urinary incontinence and leakage solutions
  • Men's sexual health improvements

Could you participate?

Eligibility for a clinical trial depends on the specific study, your health, and your history. If you're interested in learning whether a current trial might be right for you, our team can review the options. There is no obligation, and your regular care continues throughout. You can learn more about clinical trials in general at ClinicalTrials.gov.

Frequently asked questions

What is 3H Clinical Research Corporation?

It's Dr. Lief's clinical research organization, through which he serves as Principal Investigator on phase 2 and 3 urologic trials in low testosterone, enlarged prostate, and urinary leakage.

Is it safe to join a clinical trial?

Clinical trials follow strict protocols and oversight to protect participants. Dr. Lief will explain the study, risks, and benefits so you can make an informed, no-obligation decision.

Does participating cost anything?

Study-related care is typically provided at no cost to qualifying participants, and your regular care continues. Our team will review the specifics of any trial you're considering.

Interested in a clinical trial?

Ask our team whether a current study may be right for you — there's no obligation, and your regular care continues.